Latest Options News

Carnaby Resources has significantly expanded its Greater Duchess Copper Gold Project through the acquisition of the high-grade Trekelano deposit, increasing its Mineral Resource Estimate by 27% and securing a key processing partnership with Glencore.

Winsome Resources has filed a key Technical Report for its Adina Lithium Project and extended payment terms for the Renard Operation acquisition, marking significant progress in project development and regulatory engagement.

Bastion Minerals has completed its acquisition of three high-grade Canadian copper projects and raised AUD$1 million to fund exploration, positioning itself as a growing player in the energy transition metals sector.

VanEck Investments Limited has announced final dividends for a suite of its Australian and global bond ETFs, with payments scheduled for mid-February 2025. Investors are advised to note the ex-dividend dates and dividend reinvestment plan details.

Amplia Therapeutics has completed enrolment for its ACCENT Phase 2a trial in advanced pancreatic cancer two months early, reporting encouraging partial response rates and improved patient outcomes.

Lumos Diagnostics reported a robust Q2 FY25 with a 71% revenue increase to US$2.9 million, driven by strong product and service sales, alongside a strategic US$3 million BARDA partnership to advance its FebriDx test.

Bayan Mining and Minerals has secured exploration rights over a 13,406-hectare gold-rich area in southern Brazil, positioning itself near significant gold anomalies and withdrawing from its Canadian lithium option to focus on high-potential assets.

Sunshine Metals Limited reported a $179,000 net cash outflow from operating activities in the December 2024 quarter, with cash reserves standing at $1.5 million. The company is actively exploring funding options to sustain its exploration programs amid fluctuating cash flows.

Blaze Minerals secures a 60% stake in Gecko Minerals Uganda, completes initial drilling at Mityana, and raises $1.25 million to fuel exploration of critical metals in Uganda.

Race Oncology has advanced its Phase 1 clinical trial for RC220, submitting ethics approvals and bolstering its cash reserves to $18.78 million following a $5.25 million R&D tax incentive.

Axel REE Limited reports a breakthrough in its Brazilian exploration with record high-grade rare earth and gallium assays at the Caladão Project, expanding the mineralised area significantly and securing funding to advance resource definition.

Imugene Limited reports durable patient responses in multiple cancer immunotherapy trials and strengthens its financial position with a $46 million convertible note deal and a substantial R&D tax refund.